Amundi
JAZZ icon

Amundi’s Jazz Pharmaceuticals JAZZ Stock Holding History

Amundi’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$10.5M Buy
55,640
+53,454
+2,445% +$9.34M ﹤0.01% 875
2025
Q4 		$372K Buy
+2,186
New +$335K ﹤0.01% 1578
2025
Q2 		– Sell
-72,068
Closed -$8.71M – 1925
2025
Q1 		$8.71M Sell
72,068
-8,413
-10% -$1.1M ﹤0.01% 862
2024
Q4 		$9.68M Sell
80,481
-14,882
-16% -$1.75M ﹤0.01% 852
2024
Q3 		$10.3M Buy
95,363
+85,832
+901% +$9.41M ﹤0.01% 842
2024
Q2 		$987K Sell
9,531
-50,731
-84% -$5.58M ﹤0.01% 1211
2024
Q1 		$6.58M Sell
60,262
-13,181
-18% -$1.61M ﹤0.01% 915
2023
Q4 		$8.99M Buy
73,443
+10,054
+16% +$1.25M ﹤0.01% 866
2023
Q3 		$8.18M Buy
63,389
+3,958
+7% +$527K ﹤0.01% 874
2023
Q2 		$7.38M Sell
59,431
-128,453
-68% -$17.3M ﹤0.01% 914
2023
Q1 		$27.4M Buy
187,884
+23,980
+15% +$3.55M 0.01% 647
2022
Q4 		$25.4M Buy
163,904
+945
+0.6% +$139K 0.01% 650
2022
Q3 		$22.2M Buy
162,959
+31,466
+24% +$4.78M 0.01% 669
2022
Q2 		$20.4M Sell
131,493
-9,945
-7% -$1.53M 0.02% 620
2022
Q1 		$23.9M Buy
141,438
+24,989
+21% +$3.63M 0.02% 614
2021
Q4 		$16.7M Sell
116,449
-41,350
-26% -$5.43M 0.01% 723
2021
Q3 		$20.5M Buy
157,799
+147
+0.1% +$22.2K 0.01% 681
2021
Q2 		$28M Buy
+157,652
New +$27.3M 0.02% 593

Other funds holding JAZZ

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Amundi's JAZZ Position: Q1 2026 in Review

Amundi increased its Jazz Pharmaceuticals (JAZZ) stake by 2,445% in Q1 2026, buying an estimated $9.34M and bringing the position to 55,640 shares worth $10.5M. The position accounts for ﹤0.01% of the portfolio, ranked #875.

Amundi first reported a position in JAZZ in Q2 2021 and has held it in 18 quarters since. The position peaked at $28M in Q2 2021. 570 funds tracked by Wall St. Rank hold JAZZ as of Q1 2026.

  • Amundi held 55,640 shares of Jazz Pharmaceuticals worth $10.5M as of Q1 2026.
  • Amundi bought 53,454 Jazz Pharmaceuticals shares in Q1 2026, an estimated $9.34M.
  • Jazz Pharmaceuticals made up ﹤0.01% of Amundi's portfolio in Q1 2026, its #875 holding.
  • Amundi first reported a position in Jazz Pharmaceuticals in Q2 2021 and has held it in 18 quarters since.
  • Amundi's Jazz Pharmaceuticals position peaked at $28M in Q2 2021.
  • 570 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q1 2026.

Based on Amundi's 13F filing for Q1 2026, filed 18 May 2026.